Annika Langéen, Vice President Offer Management and R&D Sandvik Coromant, explains how small part machining supports precise, accurate medical device component manufacturing.
An article on Nature Medicine disclosed a thorough analysis of clinical validation data for 500+ medical AI devices, approximately half of the tools authorised by the U.S. Food and Drug Administration (FDA) lacked reported clinical validation data.
Increased demand for personalised and customised medical solutions like bioprinting is driving the 3D printing medical devices sector to rise by US$7.07 billion until 2028 at a CAGR of approximately 25.2%.